Fintel reports that on January 24, 2025, Piper Sandler upgraded their outlook for Travelers Companies (NYSE:TRV) from Neutral ...

Insurance company The Travelers Companies (NYSE:TRV) was upgraded at Piper Sandler after stronger-than-expected Q4 results, ...

In a report released today, Arvind Ramnani from Piper Sandler maintained a Hold rating on PayPal Holdings (PYPL – Research Report), with a ...

Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...

Piper Sandler analyst Anna Andreeva maintained a Hold rating on Deckers Outdoor (DECK – Research Report) today and set a price target of ...

Salesforce shows potential for growth with dominant market share and AI-driven interest from Agentforce, according to Piper ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

Shares of Travelers (NYSE: NYSE:TRV) climbed 1% as Piper Sandler shifted its stance on the insurance giant, upgrading the stock from Neutral to Overweight and significantly raising the price target ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

On Wednesday, Piper Sandler adjusted its outlook on Netflix (NASDAQ:NFLX) stock, increasing the price target to $1,100 from the prior $950 while maintaining an Overweight rating. The revision ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...